ArticleCancers2025

Serum Complement Factor H: A Marker for Progression and Outcome Prediction Towards Immunotherapy in Cutaneous Squamous Cell Carcinoma.

Glenn Geidel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.